Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Sep 5, 2022

50715_rns_2022-09-05_cc53fe57-6a3f-44e9-81a3-721065941eba.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

5 September 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase/ Sale Totalnumberof sharesinvolved Totalamount paid/ received Highest (H)prices paid/ received Lowest (L)prices paid/ received
ChinaInternationalCapitalCorporationLimited 2 September2022 Ordinaryshares Hedging as a result of the creation ofnew index-tracking ETFs where therelevant securities represent less than1% of the class in issue and less than20% of the value of the securities in thebasket or index Purchase 400 $19,684.0000 $49.2100 $49.2100

End

Note:

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.